Precision medicine and data
Prenosis Sepsis ImmunoScore
FDA De Novo-authorized AI/ML software that assigns adult emergency department or hospital patients to sepsis risk categories within a clinician-reviewed workflow.
Last updated: June 5, 2026
Back to directoryFlatiron Assist medical AI product profile
Oncology-specific clinical decision support that surfaces evidence-based regimens, biomarkers, clinical trials, and site preferences at the point of care.
Precision medicine and data
Best fit
Oncology teams that need EHR-embedded pathway support tied to NCCN content, local preferences, biomarker context, and operational reporting.
- Primary use case
- EHR-integrated oncology clinical decision support, treatment pathways, biomarkers, trials, and prior authorization support
- Audience
- Oncology practices, cancer centers, value-based care teams, and clinical pathway leaders
- Risk level
- High
- Pricing signal
- Enterprise oncology pricing; request current terms.
- Official sources
- 2 official sources
Compare within workflow: Precision medicine and data · comparison shortlist · source index
Regulatory, privacy, evidence, and workflow lens
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Flatiron Assist as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat as high-governance oncology clinical decision support; verify how pathways, NCCN content, local preferences, biomarkers, and prior-authorization workflows affect clinical accountability. |
|---|---|
| Privacy | Review EHR integration, user permissions, patient-data exchange, reporting exports, pathway analytics, and contractual PHI terms before enabling point-of-care use. |
| Evidence | Validate guideline currency, custom pathway governance, biomarker fit, trial matching, concordance reporting, and denial impact against local oncology practice. |
| Workflow | Best governed through oncology pathway committees, EHR build review, clinician override tracking, prior-authorization monitoring, and periodic pathway updates. |
Where Flatiron Assist fits
Flatiron describes Flatiron Assist as an EHR-integrated oncology clinical decision support platform that surfaces NCCN Guidelines, customizable pathways, biomarkers, clinical-trial opportunities, and reporting at the point of care.
Not for: Autonomous treatment selection without oncologist review, current guideline checks, and patient-specific clinical context.
What to verify before using Flatiron Assist
- Which cancers, regimens, biomarkers, pathways, and clinical-trial workflows are supported.
- How NCCN content and custom pathways are updated and governed.
- Whether the EHR integration captures prior-authorization and reporting fields reliably.
- How concordance, denials, clinician adoption, and treatment variation will be monitored.
Source links
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
- flatiron.com / oncology / clinical-decision-support
- resources.flatiron.com / point-of-care / cms-confirms-flatiron-assist-clinical-guidelines-meet-eom-requirements
Related medical AI products
Precision medicine and data
Anumana ECG-AI
Cardiovascular AI platform using standard 12-lead ECGs to surface signals such as low ejection fraction, pulmonary hypertension, and cardiac amyloidosis for clinician follow-up.
Precision medicine and data
Eko Health SENSORA
FDA-cleared cardiovascular detection platform that pairs Eko digital stethoscopes with AI-supported ECG and heart-sound analysis for supervised point-of-care screening.
Precision medicine and data
AliveCor Kardia 12L
Portable AI-powered 12-lead ECG system that uses a reduced leadset and KAI 12L algorithms to support clinician-reviewed cardiac determinations.